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MISSION STATEMENT
 
The International Society for Pharmacoeconomics and Outcomes Research is an international nonprofit organiza-
tion formed in 1995 to promote the practice and science of pharmacoeconomics and health outcomes assess-
ment. Its members are physicians, pharmacists, economists, nurses, and researchers from academia, the pharma-
ceutical industry, government, managed care, health research organizations, and purchasers of healthcare.
The mission of the International Society for Pharmacoeconomics and Outcomes Research is to translate pharma-
coeconomics and outcomes research into practice to ensure that society allocates scarce healthcare resources 
wisely, fairly, and efficiently.
 
OBJECTIVES
 
The society serves the public interest by the following means:
• provides a forum to facilitate the interchange of scientific knowledge in pharmacoeconomics and patient 
health outcomes;
• facilitates and encourages communications among the research community, healthcare professionals, and 
other research, regulatory, and educational groups, the communications media, and the general public by 
educating public and private agencies on the usefulness of research in pharmacoeconomic and patient 
outcomes assessment;
• acts as a resource in forming public policy relevant to the pharmacoeconomics, healthcare outcomes 
assessment, and related issues of public concern;
• promotes the science of pharmacoeconomics by providing services as may be appropriate to advance 
pharmacoeconomic and outcomes research and educational activities, represent the science of 
pharmacoeconomics and outcomes assessment before public and governmental bodies by: a) seeking 
important issues concerning healthcare interventions as they relate to pharmacoeconomics and healthcare 
outcomes; b) making available the results of pharmacoeconomics analysis and healthcare outcomes studies 
concerning these issues; c) developing scientifically-based input (evidence) for public policy decisions 
dealing with these issues; d) providing this evidence and data to governmental bodies and other public 
forums, both domestic and international, upon request;
• provides for recognition of individual achievement in the field of pharmacoeconomics and outcomes 
research;
• fosters career growth and the development of individuals involved in pharmacoeconomic and outcomes 
research and application of this research.
